The Chief Advisor of Operation War Speed, Dr. Monsep Saloi has “no contact” with the Biden administration about the infection process and the vaccine delivery process.
Since President-Elect Joe Biden won the election, President Donald Trump refused to budge and his campaign challenged the election results in court.
Despite the lack of communication with the incoming Biden administration, Saloi said he could “not” see the infection affecting the vaccine delivery process.
“We are focused on ensuring that vaccines are made available as quickly as possible and delivered as efficiently as possible, even if the political context surrounds us. Of course, we would expect the transition to be quietly and smoothly. Be ho, ”said Saloi to ABC. “We are concerned about anything that could derail this process. As it stands now, I can’t see it happening, but hopefully it won’t.”
Asked if he would be open to speaking with the Biden administration, Soloui said he would be “happy” to share the information already made public, but nothing is confidential.
Saloi told NBC’s Meet the Press, “I have been told that I should not say anything that is confidential to anyone, including anyone who is not part of the administration, and I work according to legal requirements Will do. ” Sunday.
CNBC has reached the White House for comment.
The General Services Administration has still not officially ascertained the President-Elect after which Biden won the election, which is preventing his incoming administration from accessing key resources and information. This is the “definite effect,” chief of staff Bon Ron Klan told ABC, “and those effects grow every day.”
“The President-Elect and the Vice-President-Elect are not getting the intelligence briefings they are entitled to. Our officers are not getting access to agency officials to help develop our plans, and that vaccine roll out. There is too much focus on the plan. Klein said it’s important in the early days of a Biden presidential term – we have no access.
Saloi stated that the Operation Tana motion is “separated from the administration, the political environment and the political context,” and therefore, all decisions are made [and] Whether the train is moving [it’s] One administration or the other does not matter. “
Pfizer and BioNotech then applied for an Emergency Use Authority from the Food and Drug Administration on Friday for their coronavirus vaccine. The approval process is expected to take a few weeks, with an advisory committee meeting to temporarily review the vaccine in early December.
The company announced on Monday that Modern has also planned to apply for an emergency plan, to prevent Kovad-19, according to its preliminary phase three test data, using the vaccine.
Saloi told Meet the Press on Sunday that once an Emergency Use Authority has been approved for the coronovirus vaccine, its dose will be dispatched across the country within 24 hours.
“Within 24 hours of approval, the vaccine will be ongoing and located in areas where each state has told us they want a vaccine dose,” said Saloi. “We cannot transfer vaccine doses before the Emergency Use Authority.”
Each state department of health will determine where the vaccine will be held, and with the help of the advisory committee on the Centers for Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC), each state will also decide who has previously had the vaccination, Slaoui According to.
It is likely that the vaccine will be given “on a priority basis,” Saloi said, and “it is likely, perhaps, [those that are] Health care worker, first line worker, very high risk person, elderly. “
“I hope, maybe two days after approval, on the 11th or the 12th of December, hopefully, the first people will be vaccinated across the United States, in all states, in areas that the Health Department has told us to deliver the vaccine. For, “Saloi Told CNN on Sunday.